Bionexus Gene Lab (BGLC) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access BGLC Annual Balance Sheets →
By examining balance sheet figures across successive periods, users can identify shifts in Bionexus Gene Lab's financial structure and capital allocation.
Quarterly Report, GAAP in USD millions
ITEM
(Jun 30 2026)
(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Assets
Cash & cash equivalent1.23
Deposits Assets, Current AS2.29
Cash & Short-term Investments3.00
Accounts receivable0.02
Other Receivables, Net, Current0.11
Income Taxes Receivable, Current NO0.06
Inventories0.65
Other Current Assets0.00
Total Current Assets4.94
Equipment/Property/Plant Net2.54
Long-term investments2.03
Other Assets, Noncurrent0.00
Operating Lease Right Of Use Asset0.16
Total Assets8.73
Liabilities
Accounts Payable, Trade, Current0.54
Other Accounts Payable AndAccrued Liabilities0.07
Other Liabilities, Current0.20
Customer Advances, Current0.01
Total Current Liabilities0.81
Total Long-term Debt0.00
Other liabilities, Noncurrent0.14
Amount Owing To Director Current0.13
Operating Lease Liability Current0.06
Finance Lease Liability Noncurrent0.05
Operating Lease Liability Noncurrent0.10
Total Liabilities0.95
Stockholders' Equity
Common Stock Value20.17
Additional Paid In Capital Common Stock-5.01
Retained Earnings / Accumulated Deficit-7.26
Accumulated Other Comprehensive Income-0.13
Other Equity-0.13
Common Stockholder's Equity7.78
Total Stockholder's Equity7.78
Liabilities & Stockholder's Equity8.73
4 historic quarters locked

Sign in to unlock the full Bionexus Gene Lab balance sheet history.

About Bionexus Gene Lab Corp Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-Q (Period: 20260630)
  • Filed with the SEC: August 14, 2026
  • Source: bglc_10q.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001477932-26-005093

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.